全文获取类型
收费全文 | 246659篇 |
免费 | 15689篇 |
国内免费 | 1018篇 |
专业分类
耳鼻咽喉 | 2613篇 |
儿科学 | 6461篇 |
妇产科学 | 4602篇 |
基础医学 | 30789篇 |
口腔科学 | 4461篇 |
临床医学 | 25313篇 |
内科学 | 51809篇 |
皮肤病学 | 3408篇 |
神经病学 | 24742篇 |
特种医学 | 10429篇 |
外国民族医学 | 15篇 |
外科学 | 38582篇 |
综合类 | 2705篇 |
现状与发展 | 1篇 |
一般理论 | 188篇 |
预防医学 | 17528篇 |
眼科学 | 6024篇 |
药学 | 16406篇 |
1篇 | |
中国医学 | 342篇 |
肿瘤学 | 16947篇 |
出版年
2023年 | 1390篇 |
2022年 | 2293篇 |
2021年 | 5583篇 |
2020年 | 3198篇 |
2019年 | 5270篇 |
2018年 | 6327篇 |
2017年 | 4675篇 |
2016年 | 5080篇 |
2015年 | 6031篇 |
2014年 | 8716篇 |
2013年 | 11806篇 |
2012年 | 18160篇 |
2011年 | 18905篇 |
2010年 | 10546篇 |
2009年 | 9718篇 |
2008年 | 16552篇 |
2007年 | 17455篇 |
2006年 | 16920篇 |
2005年 | 16788篇 |
2004年 | 15764篇 |
2003年 | 14397篇 |
2002年 | 13746篇 |
2001年 | 2074篇 |
2000年 | 1554篇 |
1999年 | 2130篇 |
1998年 | 2922篇 |
1997年 | 2321篇 |
1996年 | 2001篇 |
1995年 | 1851篇 |
1994年 | 1625篇 |
1993年 | 1557篇 |
1992年 | 1069篇 |
1991年 | 1004篇 |
1990年 | 841篇 |
1989年 | 817篇 |
1988年 | 744篇 |
1987年 | 654篇 |
1986年 | 688篇 |
1985年 | 737篇 |
1984年 | 962篇 |
1983年 | 835篇 |
1982年 | 1098篇 |
1981年 | 1019篇 |
1980年 | 880篇 |
1979年 | 518篇 |
1978年 | 558篇 |
1977年 | 481篇 |
1976年 | 442篇 |
1975年 | 331篇 |
1974年 | 334篇 |
排序方式: 共有10000条查询结果,搜索用时 15 毫秒
151.
Geste antagonistes, or sensory tricks, are well described in focal dystonia affecting the neck, hand, and face. Improvement in dystonic movements is typically maintained while the trick is performed, but disappears when the geste ends. We investigated the phenomenological features of geste antagoniste maneuvers in 19 patients with idiopathic lower cranial dystonia who were prospectively evaluated over a period of 6 years. Of the 19, 10 were men, mean age of onset was 49.8 years, and the most commonly involved lower cranial area was the jaw (10 patients). In most patients, dystonia was task-specific. Taking advantage of the improvement with a sensory geste, we manufactured oral appliances that mimicked the geste in 8 patients, and 3 continue to use it. 相似文献
152.
Tushar M Ranchod Daynia E Ballot Alma M Martinez Barbara J Cory Victor A Davies J Colin Partridge 《Suid-Afrikaanse tydskrif vir geneeskunde》2004,94(11):913-916
BACKGROUND: Little is known about parental experience and decision making with regard to premature infants requiring intensive care in developing countries. We undertook this study to characterise parents' experience of physician counselling and their role in making life-support decisions for very low-birth-weight (VLBW) (birth weight < 1 501 g) infants born in South Africa's public-sector neonatal intensive care units (NICUs). METHODS: Parents of surviving VLBW infants treated in three Johannesburg-area public hospitals and attending follow-up clinics in August 2001 were interviewed regarding their experience of perinatal counselling on outcomes (pain, survival, disability), perception of actual and optimal decision making, and satisfaction with NICU communication. RESULTS: Parents of 51 infants were interviewed. Seventy-five per cent of parents reported antenatal counselling by physicians on at least one perinatal topic (severe disability, pain, death, finances or religious/moral considerations). The majority of parents (> 60%) who received counselling thought that these topics had been discussed adequately. Most parents reported that doctors had the primary decision-making role, either without consulting them (41%) or after consulting them (37%). Joint decision making was rare (14%). Parents wanted more input in life-support decisions than they reported being given. CONCLUSION: Counselling is not consistently provided in public-sector hospitals in Johannesburg. Parents of premature infants want a larger share in NICU decision making than they currently experience. Most parents were satisfied with communication later during their infant's hospitalisation. South Africa presents a unique opportunity to study the use of advanced medical technologies in a nation with marked disparities in access to care. 相似文献
153.
154.
Heather S. Jim Michael A. Andrykowski Pamela N. Munster Paul B. Jacobsen 《Annals of behavioral medicine》2007,34(2):200-208
Background: Studies suggest that the period following completion of treatment can be distressing for cancer patients. One potentially
important predictor of distress is physical symptoms/side effects during treatment.Purpose: A longitudinal, observational design was used to examine whether the number of physical symptoms/side effects experienced
during treatment was a correlate of cancer-related distress and general distress 4 months after treatment completion, as measured
by the Impact of Events Scale and the Mental Health subscale of the Short Form-36, respectively.Methods: Participants were 151 women who had completed chemotherapy and/or radiotherapy for ductal carcinoma in situ or stage 1 or
2 breast cancer. Hierarchical multiple regression was conducted with relevant sociodemographic, clinical, and psychiatric
variables entered as controls.Results: Greater physical symptoms/side effects predicted greater total cancer-related distress, intrusive thoughts, and general distress.
Physical symptoms/side effects did not significantly predict avoidance. Follow-up analyses indicated that the relationship
between physical symptoms/side effects and general distress was mediated by both total cancer-related distress and intrusive
thoughts.Conclusions: These results suggest that patients who experience greater physical symptoms/side effects during treatment are at greater
risk for later cancer-related distress and, in turn, general distress. Future research should evaluate whether early intervention
with these patients is effective in preventing or reducing distress in the posttreatment period.
This work was supported by a grant from the National Cancer Institute (5R01 CA082822). 相似文献
155.
Hao Wu Colin Webber Carmen Otero Fuentes Robert Bensen Karen Beattie Jonathan D Adachi Xiaoming Xie Farhang Jabbari David R Levy 《Journal l'Association canadienne des radiologistes》2007,58(3):167-175
OBJECTIVES: 1) To assess, with a peripheral magnetic resonance imaging system (pMRI), the prevalence of bony and soft tissue abnormalities in the knee joints of normal subjects, osteoarthritis (OA) patients, and individuals who have suffered an anterior cruciate ligament (ACL) rupture; and 2) to compare the prevalence among groups. METHODS: Magnetic resonance (MR) images of 28 healthy, 32 OA, and 26 ACL damaged knees were acquired with a 1.0-T pMRI system. Two radiologists graded the presence and severity of 9 MR image features: cartilage degeneration, osteophytes, subchondral cyst, bone marrow edema, meniscal abnormality, ligament integrity, loose bodies, popliteal cysts, and joint effusion. RESULTS: Ten of 28 healthy (35.7%), 24 of 26 ACL (92.3%), and all OA knees (100%) showed prevalent cartilage defects; 5 healthy (17.9%), 20 ACL (76.9%), and all OA knees (100%) had osteophytes; and 9 normal (32.1%), 21 ACL (80.8%), and 29 OA knees (90.6%) had meniscal abnormalities. One-half of the knees in the OA group (16 of 32, 50%) had subchondral cysts, and almost one-half had bone marrow edema (15 of 32, 46.9%). These features were not common in the ACL group (7.7%, and 11.5%, respectively) and were not observed in healthy knees. The OA group had the most severe cartilage defects, osteophytes, bone marrow edema, subchondral cysts, and meniscal abnormalities; the ACL group showed more severe cartilage defects, osteophytes, and meniscal abnormalities than did normal subjects. CONCLUSION: The results suggest that knees that have sustained ACL damage have OA-like reatures; most subjects (19 of 26, 73.1%) could be identified as in the early stage of OA. The prominent abnormalities present in ACL-damaged knees are cartilage defects, osteophytes, and meniscal abnormalities. 相似文献
156.
157.
158.
159.
The AMPA receptor potentiator LY404187 increases cerebral glucose utilization and c-fos expression in the rat. 总被引:3,自引:0,他引:3
Jill H Fowler Katherine Whalley Tracey Murray Michael J O'neill James McCulloch 《Journal of cerebral blood flow and metabolism》2004,24(10):1098-1109
AMPA receptor potentiators enhance AMPA receptor-mediated glutamatergic neurotransmission and may have therapeutic potential as cognitive enhancers or antidepressants. The anatomical basis for the action of AMPA receptor potentiators is unknown. The aim of this study was to determine the effects of the biarylpropylsulfonamide AMPA receptor potentiator, LY404187 (0.05 to 5 mg/kg subcutaneously), upon cerebral glucose utilization and c-fos expression using 14C-2-deoxglucose autoradiography and c-fos immunocytochemistry. LY404187 (0.5 mg/kg) produced significant elevations in glucose utilization in 28 of the 52 anatomical regions analyzed, which included rostral neocortical areas and the hippocampus, as well the dorsal raphe nucleus, lateral habenula, and locus coeruleus. No significant decreases in glucose utilization were observed in any region after LY404187 administration. The increases in glucose utilization with LY404187 (0.5 mg/kg) were blocked by pretreatment with the AMPA receptor antagonist LY293558 (25 mg/kg), indicating that LY404187 acts through AMPA receptor-mediated mechanisms. LY404187 (0.5 mg/kg) also produced increases in c-fos immunoreactivity in the cortex, locus coeruleus, and the dorsal raphe nucleus. These studies demonstrate neuronal activation in key brain areas that are associated with memory processes and thus provide an anatomical basis for the cognitive enhancing effects of AMPA receptor potentiators. 相似文献
160.
Tobias Engelhorn Sophia Goerike Arnd Doerfler Christine Okorn Michael Forsting Gerd Heusch Rainer Schulz 《Journal of cerebral blood flow and metabolism》2004,24(4):467-474
The goal of the present study was to test the impact of administration time of the angiotensin II type 1-receptor blocker candesartan on cerebral blood flow (CBF), infarct size, and neuroscore in transient cerebral ischemia. Therefore, 1-hour middle cerebral artery occlusion (MCAO) was followed by reperfusion. Rats received 0.5-mg/kg candesartan intravenously 2 hours before MCAO (pretreatment), 24 hours after MCAO, every 24 hours after MCAO, or 2 hours before and every 24 hours after MCAO. Infarct size (mm3) and a neuroscore at day 7 were compared with controls. CBF was quantified by radiolabeled microspheres and laser-Doppler flowmetry. Compared with controls (95 +/- 8), infarct size in candesartan-treated groups was smaller (59 +/- 5, 68 +/- 10, 28 +/- 3, and 15 +/- 3, respectively; P<0.05). Although there was no difference in neuroscore between pretreatment and controls (1.55 +/- 0.18, 1.80 +/- 0.13), other treatment regimens resulted in improved neuroscores (1.33 +/- 0.16, 1.11 +/- 0.11, 0.73 +/- 0.15; P<0.05). CBF in pretreated animals at 0.5 hours after MCAO was significantly higher than in controls (0.58 +/- 0.09 mL x g(-1) x min(-1) and 44% +/- 7% of baseline compared with 0.49 +/- 0.06 mL x g(-1) x min(-1) and 37% +/- 6%, microspheres and laser-Doppler flowmetry; P<0.05). Thus, candesartan reduces infarct size even if administered only during reperfusion. Apart from pretreatment, other treatment regimens result in significantly improved neuroscores. In the acute phase of cerebral ischemia, candesartan increases CBF. 相似文献